Recombinant IL-2 Shows Potential in Atopic Dermatitis Recombinant IL-2 Shows Potential in Atopic Dermatitis

"This is the first study to demonstrate the therapeutic potential of rezpegaldesleukin," said Jonathan Silverberg, MD, PhD, MPH, who presented results of a phase 1b study.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Source Type: news